Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 8-K Event Results of operations
  2. 4 Open-market sale Director sold 11,670 shares at an average $36.82 ($429,723)
  3. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $36.72 ($50,490)
  4. 4 Open-market sale Chief Medical Officer sold 4,630 shares at $37.44 ($173,347)
  5. 4 Open-market sale Director sold 15,174 shares at an average $37.20 ($564,509)
  6. 4 Open-market sale Director sold 11,670 shares at $35.56 ($415,012)
  7. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $36.72 ($50,490)
  8. SC 13D/A Stake Beneficial Ownership Report
  9. 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $40.39 ($201,931)
  10. 4 Open-market sale Director sold 11,670 shares at an average $44.92 ($524,270)
  11. 4 Other disposition Director disposed of 4,000,000 shares (other)
  12. 4 Other disposition 10% owner disposed of 4,000,000 shares (other)
  13. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $46.63 ($64,116)
  14. 4 Open-market sale Chief Administrative Officer sold 3 shares at $50.00 ($150)
  15. 8-K Event Other events
  16. 4 Other disposition Director disposed of 1,000,000 shares (other)
  17. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  18. 4 Option exercise EVP, Research & CSO acquired 8,000 shares (option exercise)
  19. 4 Open-market sale Director sold 15,174 shares at an average $46.17 ($700,515)
  20. 4 Open-market sale Director sold 11,670 shares at $43.95 ($512,840)

Page 27 of 41 · 806 filings